End C - Search Results

1

Generation of a vector system facilitating cloning of DMBT1 variants and recombinant expression of functional full-length DMBT1.

End C, Lyer S, Renner M, Stahl C, Ditzer J, Holloschi A, Kuhn HM, Flammann HT, Poustka A, Hafner M, Mollenhauer J, Kioschis P. End C, et al. Protein Expr Purif. 2005 Jun;41(2):275-86. doi: 10.1016/j.pep.2005.02.010. Protein Expr Purif. 2005. PMID: 15866713

2

Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion.

Rosenstiel P, Sina C, End C, Renner M, Lyer S, Till A, Hellmig S, Nikolaus S, Fölsch UR, Helmke B, Autschbach F, Schirmacher P, Kioschis P, Hafner M, Poustka A, Mollenhauer J, Schreiber S. Rosenstiel P, et al. Among authors: end c. J Immunol. 2007 Jun 15;178(12):8203-11. doi: 10.4049/jimmunol.178.12.8203. J Immunol. 2007. PMID: 17548659

3

DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease.

Renner M, Bergmann G, Krebs I, End C, Lyer S, Hilberg F, Helmke B, Gassler N, Autschbach F, Bikker F, Strobel-Freidekind O, Gronert-Sum S, Benner A, Blaich S, Wittig R, Hudler M, Ligtenberg AJ, Madsen J, Holmskov U, Annese V, Latiano A, Schirmacher P, Amerongen AV, D'Amato M, Kioschis P, Hafner M, Poustka A, Mollenhauer J. Renner M, et al. Among authors: end c. Gastroenterology. 2007 Nov;133(5):1499-509. doi: 10.1053/j.gastro.2007.08.007. Epub 2007 Aug 3. Gastroenterology. 2007. PMID: 17983803

4

DMBT1 functions as pattern-recognition molecule for poly-sulfated and poly-phosphorylated ligands.

End C, Bikker F, Renner M, Bergmann G, Lyer S, Blaich S, Hudler M, Helmke B, Gassler N, Autschbach F, Ligtenberg AJ, Benner A, Holmskov U, Schirmacher P, Nieuw Amerongen AV, Rosenstiel P, Sina C, Franke A, Hafner M, Kioschis P, Schreiber S, Poustka A, Mollenhauer J. End C, et al. Eur J Immunol. 2009 Mar;39(3):833-42. doi: 10.1002/eji.200838689. Eur J Immunol. 2009. PMID: 19189310 Free article.

5

The scavenging capacity of DMBT1 is impaired by germline deletions.

Bikker FJ, End C, Ligtenberg AJM, Blaich S, Lyer S, Renner M, Wittig R, Nazmi K, van Nieuw Amerongen A, Poustka A, Veerman ECI, Mollenhauer J. Bikker FJ, et al. Among authors: end c. Immunogenetics. 2017 Jun;69(6):401-407. doi: 10.1007/s00251-017-0982-x. Epub 2017 Mar 31. Immunogenetics. 2017. PMID: 28364129 Free PMC article.

6

Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains.

Bikker FJ, Ligtenberg AJ, End C, Renner M, Blaich S, Lyer S, Wittig R, van't Hof W, Veerman EC, Nazmi K, de Blieck-Hogervorst JM, Kioschis P, Nieuw Amerongen AV, Poustka A, Mollenhauer J. Bikker FJ, et al. Among authors: end c. J Biol Chem. 2004 Nov 12;279(46):47699-703. doi: 10.1074/jbc.M406095200. Epub 2004 Sep 7. J Biol Chem. 2004. PMID: 15355985 Free article.

7

Deleted in Malignant Brain Tumors 1 (DMBT1) is present in hyaline membranes and modulates surface tension of surfactant.

Müller H, End C, Renner M, Helmke BM, Gassler N, Weiss C, Hartl D, Griese M, Hafner M, Poustka A, Mollenhauer J, Poeschl J. Müller H, et al. Among authors: end c. Respir Res. 2007 Oct 1;8(1):69. doi: 10.1186/1465-9921-8-69. Respir Res. 2007. PMID: 17908325 Free PMC article.

8

Respiratory Deleted in Malignant Brain Tumours 1 (DMBT1) levels increase during lung maturation and infection.

Müller H, End C, Weiss C, Renner M, Bhandiwad A, Helmke BM, Gassler N, Hafner M, Poustka A, Mollenhauer J, Poeschl J. Müller H, et al. Among authors: end c. Clin Exp Immunol. 2008 Jan;151(1):123-9. doi: 10.1111/j.1365-2249.2007.03528.x. Epub 2007 Nov 7. Clin Exp Immunol. 2008. PMID: 17991292 Free PMC article.

9

Deleted in Malignant Brain Tumors 1 is up-regulated in bacterial endocarditis and binds to components of vegetations.

Müller H, Renner M, Helmke BM, End C, Weiss C, Poeschl J, Mollenhauer J. Müller H, et al. Among authors: end c. J Thorac Cardiovasc Surg. 2009 Sep;138(3):725-32. doi: 10.1016/j.jtcvs.2009.05.021. Epub 2009 Jul 1. J Thorac Cardiovasc Surg. 2009. PMID: 19698862 Free article.

10

Construction of biosensor systems for determining the pathophysiological potential of carrageenan variants.

Riedel A, End C, Christiansen H, Renner M, Bender C, Schmidt S, Korn B, Sueltmann H, Mollenhauer J. Riedel A, et al. Among authors: end c. Mol Biosyst. 2009 Sep;5(9):973-9. doi: 10.1039/b901882b. Epub 2009 May 13. Mol Biosyst. 2009. PMID: 19668862

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page